HEADER HYDROLASE 03-NOV-99 1DBX TITLE CRYSTAL STRUCTURE OF CYSTEINYL-TRNA(PRO) DEACYLASE FROM H. INFLUENZAE TITLE 2 (HI1434) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTEINYL-TRNA(PRO) DEACYLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HI1434; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE; SOURCE 3 ORGANISM_TAXID: 727; SOURCE 4 GENE: YBAK; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: B834; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: YCYB2; SOURCE 9 OTHER_DETAILS: IMPACT I SYSTEM FROM NEW ENGLAND BIOLABS KEYWDS STRUCTURAL GENOMICS, YBAK, STRUCTURE 2 FUNCTION PROJECT, S2F, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.ZHANG,K.HUANG,Z.LI,O.HERZBERG,STRUCTURE 2 FUNCTION PROJECT (S2F) REVDAT 6 30-OCT-24 1DBX 1 REMARK REVDAT 5 15-NOV-23 1DBX 1 REMARK REVDAT 4 09-AUG-23 1DBX 1 SEQADV LINK REVDAT 3 24-FEB-09 1DBX 1 VERSN REVDAT 2 21-SEP-04 1DBX 1 TITLE COMPND SOURCE HEADER REVDAT 2 2 1 KEYWDS REVDAT 1 14-JUN-00 1DBX 0 JRNL AUTH H.ZHANG,K.HUANG,Z.LI,L.BANERJEI,K.E.FISHER,N.V.GRISHIN, JRNL AUTH 2 E.EISENSTEIN,O.HERZBERG JRNL TITL CRYSTAL STRUCTURE OF YBAK PROTEIN FROM HAEMOPHILUS JRNL TITL 2 INFLUENZAE (HI1434) AT 1.8 A RESOLUTION: FUNCTIONAL JRNL TITL 3 IMPLICATIONS. JRNL REF PROTEINS V. 40 86 2000 JRNL REFN ISSN 0887-3585 JRNL PMID 10813833 JRNL DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO JRNL DOI 2 ;2-Y REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 24752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE-R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2446 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2304 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 374 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.170 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.172 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.013 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.032 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DBX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-NOV-99. REMARK 100 THE DEPOSITION ID IS D_1000009955. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-OCT-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9500 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49134 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.12900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: YBAK STRUCTURE IN C2 SPACE GROUP, 1DBU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 28.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 25 REMARK 465 ASN A 26 REMARK 465 GLN A 27 REMARK 465 HIS A 28 REMARK 465 PHE A 29 REMARK 465 MET B 1 REMARK 465 ASN B 25 REMARK 465 ASN B 26 REMARK 465 GLN B 27 REMARK 465 HIS B 28 REMARK 465 PHE B 29 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR A 2 N - CA - CB ANGL. DEV. = -15.4 DEGREES REMARK 500 ARG A 43 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 VAL A 50 N - CA - CB ANGL. DEV. = -13.3 DEGREES REMARK 500 ARG A 111 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 VAL B 84 N - CA - CB ANGL. DEV. = -14.0 DEGREES REMARK 500 LEU B 106 CA - CB - CG ANGL. DEV. = 22.9 DEGREES REMARK 500 ASP B 154 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 31 63.90 -174.18 REMARK 500 ASP A 157 -139.38 -73.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP B 157 GLU B 158 141.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DBU RELATED DB: PDB REMARK 900 RELATED ID: HI1434 RELATED DB: TARGETDB DBREF 1DBX A 1 158 UNP P45202 Y1434_HAEIN 1 158 DBREF 1DBX B 1 158 UNP P45202 Y1434_HAEIN 1 158 SEQADV 1DBX MSE A 69 UNP P45202 MET 69 MODIFIED RESIDUE SEQADV 1DBX MSE A 86 UNP P45202 MET 86 MODIFIED RESIDUE SEQADV 1DBX ASN A 117 UNP P45202 LYS 117 SEE REMARK 999 SEQADV 1DBX MSE B 69 UNP P45202 MET 69 MODIFIED RESIDUE SEQADV 1DBX MSE B 86 UNP P45202 MET 86 MODIFIED RESIDUE SEQADV 1DBX ASN B 117 UNP P45202 LYS 117 SEE REMARK 999 SEQRES 1 A 158 MET THR PRO ALA ILE ASP LEU LEU LYS LYS GLN LYS ILE SEQRES 2 A 158 PRO PHE ILE LEU HIS THR TYR ASP HIS ASP PRO ASN ASN SEQRES 3 A 158 GLN HIS PHE GLY ASP GLU ALA ALA GLU LYS LEU GLY ILE SEQRES 4 A 158 ASP PRO ASN ARG SER PHE LYS THR LEU LEU VAL ALA GLU SEQRES 5 A 158 ASN GLY ASP GLN LYS LYS LEU ALA CYS PHE VAL LEU ALA SEQRES 6 A 158 THR ALA ASN MSE LEU ASN LEU LYS LYS ALA ALA LYS SER SEQRES 7 A 158 ILE GLY VAL LYS LYS VAL GLU MSE ALA ASP LYS ASP ALA SEQRES 8 A 158 ALA GLN LYS SER THR GLY TYR LEU VAL GLY GLY ILE SER SEQRES 9 A 158 PRO LEU GLY GLN LYS LYS ARG VAL LYS THR VAL ILE ASN SEQRES 10 A 158 SER THR ALA LEU GLU PHE GLU THR ILE TYR VAL SER GLY SEQRES 11 A 158 GLY LYS ARG GLY LEU SER VAL GLU ILE ALA PRO GLN ASP SEQRES 12 A 158 LEU ALA LYS VAL LEU GLY ALA GLU PHE THR ASP ILE VAL SEQRES 13 A 158 ASP GLU SEQRES 1 B 158 MET THR PRO ALA ILE ASP LEU LEU LYS LYS GLN LYS ILE SEQRES 2 B 158 PRO PHE ILE LEU HIS THR TYR ASP HIS ASP PRO ASN ASN SEQRES 3 B 158 GLN HIS PHE GLY ASP GLU ALA ALA GLU LYS LEU GLY ILE SEQRES 4 B 158 ASP PRO ASN ARG SER PHE LYS THR LEU LEU VAL ALA GLU SEQRES 5 B 158 ASN GLY ASP GLN LYS LYS LEU ALA CYS PHE VAL LEU ALA SEQRES 6 B 158 THR ALA ASN MSE LEU ASN LEU LYS LYS ALA ALA LYS SER SEQRES 7 B 158 ILE GLY VAL LYS LYS VAL GLU MSE ALA ASP LYS ASP ALA SEQRES 8 B 158 ALA GLN LYS SER THR GLY TYR LEU VAL GLY GLY ILE SER SEQRES 9 B 158 PRO LEU GLY GLN LYS LYS ARG VAL LYS THR VAL ILE ASN SEQRES 10 B 158 SER THR ALA LEU GLU PHE GLU THR ILE TYR VAL SER GLY SEQRES 11 B 158 GLY LYS ARG GLY LEU SER VAL GLU ILE ALA PRO GLN ASP SEQRES 12 B 158 LEU ALA LYS VAL LEU GLY ALA GLU PHE THR ASP ILE VAL SEQRES 13 B 158 ASP GLU MODRES 1DBX MSE A 69 MET SELENOMETHIONINE MODRES 1DBX MSE A 86 MET SELENOMETHIONINE MODRES 1DBX MSE B 69 MET SELENOMETHIONINE MODRES 1DBX MSE B 86 MET SELENOMETHIONINE HET MSE A 69 8 HET MSE A 86 8 HET MSE B 69 8 HET MSE B 86 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 3 HOH *374(H2 O) HELIX 1 1 THR A 2 LYS A 12 1 11 HELIX 2 2 ASP A 31 GLY A 38 1 8 HELIX 3 3 ASP A 40 ARG A 43 5 4 HELIX 4 4 ASN A 71 ILE A 79 1 9 HELIX 5 5 ASP A 88 GLY A 97 1 10 HELIX 6 6 THR A 119 PHE A 123 5 5 HELIX 7 7 ALA A 140 GLY A 149 1 10 HELIX 8 8 THR B 2 LYS B 12 1 11 HELIX 9 9 ASP B 31 GLY B 38 1 8 HELIX 10 10 ASP B 40 ASN B 42 5 3 HELIX 11 11 ASN B 71 ILE B 79 1 9 HELIX 12 12 ASP B 88 GLY B 97 1 10 HELIX 13 13 THR B 119 PHE B 123 5 5 HELIX 14 14 ALA B 140 GLY B 149 1 10 SHEET 1 A 3 ILE A 16 THR A 19 0 SHEET 2 A 3 LEU A 135 ILE A 139 -1 O SER A 136 N HIS A 18 SHEET 3 A 3 ILE A 126 SER A 129 -1 N ILE A 126 O ILE A 139 SHEET 1 B 5 VAL A 84 MSE A 86 0 SHEET 2 B 5 PHE A 45 GLU A 52 -1 N ALA A 51 O GLU A 85 SHEET 3 B 5 LEU A 59 ALA A 65 -1 O ALA A 60 N VAL A 50 SHEET 4 B 5 THR A 114 ASN A 117 1 O VAL A 115 N VAL A 63 SHEET 5 B 5 GLU A 151 THR A 153 1 O GLU A 151 N ILE A 116 SHEET 1 C 5 GLU B 151 THR B 153 0 SHEET 2 C 5 THR B 114 ASN B 117 1 O THR B 114 N GLU B 151 SHEET 3 C 5 ASP B 55 ALA B 65 1 O CYS B 61 N VAL B 115 SHEET 4 C 5 SER B 44 GLU B 52 -1 N LYS B 46 O LEU B 64 SHEET 5 C 5 VAL B 84 MSE B 86 -1 O GLU B 85 N ALA B 51 SHEET 1 C1 7 GLU B 151 THR B 153 0 SHEET 2 C1 7 THR B 114 ASN B 117 1 O THR B 114 N GLU B 151 SHEET 3 C1 7 ASP B 55 ALA B 65 1 O CYS B 61 N VAL B 115 SHEET 4 C1 7 SER B 44 GLU B 52 -1 N LYS B 46 O LEU B 64 SHEET 5 C1 7 ILE B 126 SER B 129 1 O TYR B 127 N PHE B 45 SHEET 6 C1 7 LEU B 135 ILE B 139 -1 N VAL B 137 O VAL B 128 SHEET 7 C1 7 ILE B 16 THR B 19 -1 O ILE B 16 N GLU B 138 LINK C ASN A 68 N MSE A 69 1555 1555 1.33 LINK C MSE A 69 N LEU A 70 1555 1555 1.32 LINK C GLU A 85 N MSE A 86 1555 1555 1.32 LINK C MSE A 86 N ALA A 87 1555 1555 1.35 LINK C ASN B 68 N MSE B 69 1555 1555 1.34 LINK C MSE B 69 N LEU B 70 1555 1555 1.34 LINK C GLU B 85 N MSE B 86 1555 1555 1.32 LINK C MSE B 86 N ALA B 87 1555 1555 1.33 CRYST1 32.560 42.210 54.160 109.07 100.32 90.62 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030710 0.000330 0.006050 0.00000 SCALE2 0.000000 0.023690 0.008400 0.00000 SCALE3 0.000000 0.000000 0.019910 0.00000